This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valentine-Thon, E.
Right arrow Articles by Cleator, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valentine-Thon, E.
Right arrow Articles by Cleator, G. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2001, p. 4407-4412, Vol. 39, No. 12
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.12.4407-4412.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

European Proficiency Testing Program for Molecular Detection and Quantitation of Hepatitis B Virus DNA

Elizabeth Valentine-Thon,1,* Anton M. van Loon,2 Jurjen Schirm,3 Jim Reid,4 Paul E. Klapper,5 and Graham M. Cleator5

Department of Molecular Biology, Laboratory Dr. Schiwara and Partners, 28357 Bremen, Germany1; Department of Virology, University Medical Center Utrecht, Utrecht,2 and Department of Virology, Regional Public Health Laboratory, Groningen,3 The Netherlands; and Shield Diagnostics Limited, Dundee,4 and Department of Virology, Manchester Royal Infirmary, Manchester,5 United Kingdom

Received 30 April 2001/Returned for modification 14 August 2001/Accepted 27 September 2001

External quality control of hepatitis B virus (HBV) DNA detection remains an important issue. This study reports and compares the results obtained from two different proficiency panels for both the qualitative and quantitative assessment of HBV DNA. The panels were designed by the European Union Quality Control Concerted Action, prepared by Boston Biomedica, Inc., and distributed in May 1999 (panel 1) and February 2000 (panel 2). Each contained two negative samples and six positive samples with 103 to 107 copies/ml (panel 1) or 103 to 2 × 106 copies of HBV DNA per ml (panel 2). For panel 1, 42 laboratories submitted 20 qualitative (all in-house PCRs) and 37 quantitative (87% commercial assays) data sets. For panel 2, 51 laboratories submitted 25 qualitative (all in-house PCRs) and 47 quantitative (94% commercial assays) data sets. Five data sets (8.8%) in panel 1 and two data sets (2.8%) in panel 2 contained totals of six and two false-positives, respectively, corresponding to false-positive result rates of 5.3% for panel 1 and 1.4% for panel 2. The false-negative result rates of 10.5% for panel 1 and 17.4% for panel 2 were dependent on the detection levels of the assays employed as well as panel composition. In the qualitative analysis of all data sets, 47.4% (panel 1) and 51.4% (panel 2) had all samples correct. An adequate or better score (all correct or only the weak-positive sample missed) was obtained with 77.2% of the panel 1 samples and 68.1% of the panel 2 samples. In the quantitative analysis, 57.1% (panel 1) and 42.6% (panel 2) of the data sets achieved an adequate or better score (positive results within the acceptable range of the geometric mean ± 0.5 log10 of all positive results). These results demonstrate that while the qualitative performance of HBV detection has considerably improved compared to that of a previously published HBV proficiency study, the detection levels of many commercial quantitative assays are still too high to allow adequate quantitation of all relevant clinical samples.


* Corresponding author. Mailing address: Department of Molecular Biology, Laboratory Dr. Schiwara and Partners, Haferwende 12, 28357 Bremen, Germany. Phone: 0049-421-20720. Fax: 0049-421-2072-167. E-mail: Elizabeth.Valentine-Thon{at}Schiwara.de.


Journal of Clinical Microbiology, December 2001, p. 4407-4412, Vol. 39, No. 12
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.12.4407-4412.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Loth, L., Prijono, W. B., Wibawa, H., Usman, T. B. (2008). Evaluation of two avian influenza type A rapid antigen tests under Indonesian field conditions. jvdi 20: 642-644 [Abstract] [Full Text]  
  • Niedrig, M., Meyer, H., Panning, M., Drosten, C. (2006). Follow-Up on Diagnostic Proficiency of Laboratories Equipped To Perform Orthopoxvirus Detection and Quantification by PCR: the Second International External Quality Assurance Study. J. Clin. Microbiol. 44: 1283-1287 [Abstract] [Full Text]  
  • Patton, S. J., Wallace, A. J., Elles, R. (2006). Benchmark for Evaluating the Quality of DNA Sequencing: Proposal from an International External Quality Assessment Scheme. Clin. Chem. 52: 728-736 [Abstract] [Full Text]  
  • Loens, K., Beck, T., Ursi, D., Pattyn, S., Goossens, H., Ieven, M. (2006). Two Quality Control Exercises Involving Nucleic Acid Amplification Methods for Detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and Carried Out 2 Years Apart (in 2002 and 2004).. J. Clin. Microbiol. 44: 899-908 [Abstract] [Full Text]  
  • Quint, W. G. V., Pagliusi, S. R., Lelie, N., de Villiers, E.-M., Wheeler, C. M., the World Health Organization Human Papillomavirus, (2006). Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA. J. Clin. Microbiol. 44: 571-579 [Abstract] [Full Text]  
  • Muyldermans, G., Soetens, O., Antoine, M., Bruisten, S., Vincart, B., Doucet-Populaire, F., Fry, N. K., Olcen, P., Scheftel, J. M., Senterre, J. M., van der Zee, A., Riffelmann, M., Pierard, D., Lauwers, S. (2005). External Quality Assessment for Molecular Detection of Bordetella pertussis in European Laboratories. J. Clin. Microbiol. 43: 30-35 [Abstract] [Full Text]  
  • Shyamala, V., Arcangel, P., Cottrell, J., Coit, D., Medina-Selby, A., McCoin, C., Madriaga, D., Chien, D., Phelps, B. (2004). Assessment of the Target-Capture PCR Hepatitis B Virus (HBV) DNA Quantitative Assay and Comparison with Commercial HBV DNA Quantitative Assays. J. Clin. Microbiol. 42: 5199-5204 [Abstract] [Full Text]  
  • Keilholz, U., Goldin-Lang, P., Bechrakis, N. E., Max, N., Letsch, A., Schmittel, A., Scheibenbogen, C., Heufelder, K., Eggermont, A., Thiel, E. (2004). Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction. Clin. Cancer Res. 10: 1605-1612 [Abstract] [Full Text]  
  • Leb, V., Stocher, M., Valentine-Thon, E., Holzl, G., Kessler, H., Stekel, H., Berg, J. (2004). Fully Automated, Internally Controlled Quantification of Hepatitis B Virus DNA by Real-Time PCR by Use of the MagNA Pure LC and LightCycler Instruments. J. Clin. Microbiol. 42: 585-590 [Abstract] [Full Text]  
  • Verkooyen, R. P., Noordhoek, G. T., Klapper, P. E., Reid, J., Schirm, J., Cleator, G. M., Ieven, M., Hoddevik, G. (2003). Reliability of Nucleic Acid Amplification Methods for Detection of Chlamydia trachomatis in Urine: Results of the First International Collaborative Quality Control Study among 96 Laboratories. J. Clin. Microbiol. 41: 3013-3016 [Abstract] [Full Text]  
  • Raggi, C. C., Pinzani, P., Paradiso, A., Pazzagli, M., Orlando, C. (2003). External Quality Assurance Program for PCR Amplification of Genomic DNA: An Italian Experience. Clin. Chem. 49: 782-791 [Abstract] [Full Text]  
  • Schirm, J., van Loon, A. M., Valentine-Thon, E., Klapper, P. E., Reid, J., Cleator, G. M. (2002). External Quality Assessment Program for Qualitative and Quantitative Detection of Hepatitis C Virus RNA in Diagnostic Virology. J. Clin. Microbiol. 40: 2973-2980 [Abstract] [Full Text]  
  • Berger, A., Preiser, W. (2002). Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. J Antimicrob Chemother 49: 713-721 [Abstract] [Full Text]